Hyperexcitability and the imbalance of excitation/inhibition are one of the leading causes of abnormal sensory processing in Fragile X syndrome (FXS). The precise timing and distribution of excitation and inhibition is crucial for auditory processing at the level of the auditory brainstem, which is responsible for sound localization ability. Sound localization is one of the sensory abilities disrupted by loss of the Fragile X Mental Retardation 1 (Fmr1) gene. Using triple immunofluorescence staining we tested whether there were alterations in the number and size of presynaptic structures for the three primary neurotransmitters (glutamate, glycine, and GABA) in the auditory brainstem of Fmr1 knockout mice. We found decreases in either glycinergic or GABAergic inhibition to the medial nucleus of the trapezoid body (MNTB) specific to the tonotopic location within the nucleus. MNTB is one of the primary inhibitory nuclei in the auditory brainstem and participates in the sound localization process with fast and well-timed inhibition. Thus, a decrease in inhibitory afferents to MNTB neurons should lead to greater inhibitory output to the projections from this nucleus. In contrast, we did not see any other significant alterations in balance of excitation/inhibition in any of the other auditory brainstem nuclei measured, suggesting that the alterations observed in the MNTB are both nucleus and frequency specific. We furthermore show that glycinergic inhibition may be an important contributor to imbalances in excitation and inhibition in FXS and that the auditory brainstem is a useful circuit for testing these imbalances.
ingly, sound localization deficits have not been rigorously studied in either humans or in a mouse model of FXS. Similar auditory deficits have been seen in other disorders such as central auditory processing disorder (Shamma, 2008) and some forms of age-related hearing loss Goossens, Vercammen, Wouters, & Wieringen, 2016; He, Mills, Ahlstrom, & Dubno, 2008) . For these latter conditions, the connection between the symptoms (trouble with sound localization and noisy environment cue disruption) and changes in excitation and inhibition in the sound localization pathway is better understood (Shamma, 2008) . The hypothesis of the current study is that the auditory symptoms seen in FXS are due to an overall imbalance of excitatory and inhibitory synaptic inputs in the sound localization circuit located in the auditory brainstem. We will test this hypothesis by examining whether there are anatomical changes to glycinergic, GABAergic, and glutamatergic synapses in the auditory brainstem that may underlie physiological changes to these synapses.
The auditory brainstem network is made up of discrete nuclei that are responsible for different aspects of sound stimulus encoding. Sound information that leaves the cochlea travels down the auditory nerve and projects glutamatergic excitation onto the anteroventral cochlear nucleus (AVCN). The AVCN then transmits this information to several nuclei via strong glutamatergic synapses (Thompson & Schofield, 2000) . One of these synapses is known as the calyx of Held and is a crossed projection from the AVCN to the medial nucleus of the trapezoid body (MNTB). Additionally, the AVCN also projects excitatory synapses contralaterally to the ventral nucleus of the trapezoid body (VNTB) (Thompson & Schofield, 2000; Robertson, 1996) . The VNTB is known to project inhibitory input to the MNTB to fine-tune neural responses from the AVCN input (Albrecht, Dondzillo, Mayer, Thompson, & Klug, 2014; Kuwabara, DiCaprio, & Zook, 1991) . Both the AVCN and MNTB project to the lateral superior olive (LSO); however, AVCN projects glutamatergic excitation from the ipsilateral ear, whereas MNTB contributes fast and well-timed glycinergic inhibition from the contralateral ear (Spangler, Warr, & Henkel, 1985) , reviewed in Grothe, Pecka, and McAlpine, (2010) and Tollin (2003) . The LSO is a specialized nucleus responsible primarily for processing of interaural level differences (ILDs). These differences are detected via excitation from the ear with higher level (sound pressure) through AVCN glutamatergic synapses and via inhibition from glycinergic synapses (MNTB) of the excitation from the contralateral ear further from the intense sound (Boudreau & Tsuchitani, 1968; Tsuchitani, 1977) .
Several anatomical studies of autistic individuals have shown alterations in the size and orientation of brainstem nuclei, specifically a reduction in cell number within MNTB, MSO, and LSO (Kulesza & Mangunay, 2008; Kulesza, Lukose, & Stevens, 2011) . In an FXS knockout rat model, many brainstem neurons had smaller soma and in the superior paraolivary nucleus (SPN) there was reduced expression of glutamic acid decarboxylase (GAD67) (Ruby, Falvey, & Kulesza, 2015) .
In the same study, the authors showed a reduction in number of calretinin positive terminals, which is a marker for calyx axons and terminals in the MNTB (Ruby et al., 2015) . Another study in FXS mice showed increased vesicular GABA transporter protein (VGAT) staining in the MNTB compared to controls and smaller cell size in the MNTB and VCN of FXS mice (Rotschafer, Marshak, & Cramer, 2015) . These results suggest that there are alterations in the balance of excitatory and inhibitory inputs to the auditory brainstem nuclei in FXS consistent with the hypothesis that hyperexcitability of sensory systems are one of the key components to altered sensory processing in autism and FXS (Rubenstein & Merzenich, 2003) . However, none of these studies have investigated whether there are changes in glycinergic inhibition, which is the primary inhibitory neurotransmitter, in the auditory brainstem.
The current study aims to understand how loss of FMRP may change the presynaptic inputs onto auditory brainstem nuclei. We investigated whether there were changes in glutamatergic, GABAergic or glycinergic presynaptic structures in areas of the brainstem known to be important in the sound localization pathway. Specifically, we investigated the AVCN, VNTB, MNTB, and the LSO of Fmr1 2/2 mice.
To achieve these aims, we performed triple immunofluorescence for vesicular glutamate transporter 2 (VGLUT2-a presynaptic glutamatergic marker), glutamate decarboxylase 67 (GAD67-a presynaptic GABAergic marker), and glycine transporter 2 (GlyT2-a presynaptic glycinergic marker). The end goal of this study is to determine if there are anatomical changes to these auditory brainstem nuclei that may underlie and lead to functional changes in this circuit.
10 min) in PBS and covered in 4% agarose. Fixed brains were then sliced into 100 lm coronal sections with a Vibratome (Leica VT1000s, Nussloch, Germany) that included, AVCN, MNTB, LSO, and VNTB.
| Immunofluorescence
Once the brainstem was sliced into roughly 10-20 sections/animal, free-floating slices were blocked in antibody media (AB media: 0.1 M phosphate buffer (PB: 50 mM KH 2 PO 4 , 150 mM Na 2 HPO 4 ), 150 mM NaCL, 3 mM Triton-X, 1% bovine serum albumin (BSA) and 5% normal goat serum (NGS) for 1 hr. In some animals Fab fragments (Jackson Immunoresearch, Westgrove, PA) were used in this step to increase the specificity of mouse on mouse primary antibody. However, there was no difference seen between sections within genotype containing Fab fragments versus those without and therefore Fab fragment use was discontinued. Following blocking, slices were incubated with primary antibody for GAD67, GlyT2, and VGLUT2 (Table 1, antibody characterization below) diluted in AB media and 1% NGS overnight at 48C. Slices were then washed (3 3 10 min) in PBS followed by secondary antibody (Table 2 , Thermo-Fisher, Waltham, MA) diluted in AB media and 1% NGS incubated for 1 hr at room temperature. Slices were then washed in PB and mounted on glass slides using Birmingham, AL) and coverslipped.
| Antibody characterization
Three primary antibodies were used for detection of GlyT2, GAD67, or VGLUT2, listed in Table 1 . To visualize these primary antibodies, three complimentary fluorescent-conjugated secondary antibodies were used, listed in (Rotschafer et al., 2015 (mouse), Cooper & Gillespie, 2011 ).
| Imaging
Slides with brainstem slices were imaged using an Olympus FV1000 confocal microscope (Olympus, Tokyo, Japan). High-resolution (512 3 512 pixel), 603 oil (numerical aperture 1.4), Z-stacks were taken through each section in 20 steps. Voxel volume varied between 0.09
) and 0.10 lm 3 (B6) for the AVCN (n.s., p 5.27), 0.07 ) and 0.10 lm 3 (B6) for the medial LSO (n.s. 
| Quantification of images
Confocal image stacks were loaded into imstack using the bioformats toolbox (http://downloads.openmicroscopy.org/bio-formats/5.2.4/). Zstacks for each channel were processed independently. To reduce background noise and eliminate uneven illumination, we performed a median and top-hat filter. We next used Otsu's method (Otsu, 1979) to calculate a threshold value for the entire stack. Due to the staining differences among the various nuclei type (e.g., Calyx of Held) that we examined, the threshold value was multiplied by a factor (e.g., 0.5, 1) to ensure that the threshold intensity value fell above the background signal but below the intensity values for visually identified "presynaptic structures", thus maximizing the signal-to-noise ratio. For any given nucleus type, the same factor was used across genotypes. The image stack was then binarized using this adjusted threshold value. In this new, binarized stack, voxels with intensity values above the adjusted threshold value had a value of 1 and were considered to contain signal for GAD67, GlyT2, and VGLUT2 in the red, green, and blue channels, respectively. All other voxels in the binarized stack had a value of 0.
For each channel, positive voxels throughout the z-stack were clustered into three-dimensional connected-components (contiguous groups of voxels) using a neighborhood connectivity of 26. A 26-connected voxel is a neighbor to other voxels that touches on its faces, edges, or corners. We then used the MATLAB region props function to calculate the volumes and centroid for each connected-component.
Next we calculated the mean volume 1 one standard deviation of all connected-components and used this value as our structure cut-off. In order to exclude any axons from our analysis, connected-components with volumes larger than the cut-off were eliminated while the remaining connected-components (with volumes falling below this cut-off)
were considered to represent presynaptic structures. Thresholded images are included in each image figure (panels d, h) to illustrate the quantification of the images.
| Statistical analysis
Graphs were generated using Python (Python Software Foundation.
Python Language Reference, version 2.7. Available at http://www. Index of synaptic protein, see Rotschafer et al., 2015) was calculated using the value generated from the custom Matlab software that corresponded with number of pixels, in this case further called "presynaptic structures". The I sp for GAD67 can be calculated as a ratio of (VGLUT2-GAD67)/(VGLUT2 1 GAD67). The I sp for GlyT2 can be calculated as a ratio: (VGLUT2-GlyT2)/(VGLUT2 1 GlyT2). For both GlyT2 and GAD67 I sp , higher I sp values can be considered greater excitation than inhibition (Rotschafer et al., 2015) . I sp results were also analyzed using a mixed effect model with a Holms p value correction for multiple comparisons. Representative images were adjusted for brightness and contrast using Photoshop (Adobe Photoshop CS6, Mountainview, CA)
purely for the purposes of illustration. All analyses were completed on unadjusted (by Photoshop) images only.
| R ESU L TS
We used triple immunofluorescence staining in paraformaldehyde fixed tissue from Fmr1 2/2 mice and B6 controls to examine the presynaptic inputs (glutamatergic, glycinergic, and GABAergic) to different nuclei of the auditory brainstem to determine if there are imbalances in (e-h) mice, respectively. Representative images for GAD67 (a, e), GlyT2 (b, f), VGLUT2 (c, g) and thresholded (d, h) staining of VGLUT2/ GlyT2/GAD67 markers in B6 and Fmr1 2/2 mice, respectively. Scale bar is 20 microns excitatory and inhibitory projections that might lead to sound localization issues in FXS.
| Presynaptic structures of the AVCN
We first examined the inputs to the AVCN since it's the first nucleus along the ascending auditory pathway and receives excitatory input directly from the auditory nerve (Figures 1 & 2) . Inhibitory inputs to this nucleus have been demonstrated (Adams & Mugnaini, 1987; Juiz, Helfert, Bonneau, Wenthold, & Altschuler, 1989; Mahendrasingam, Wallam, & Hackney, 2000; Saint Marie, Benson, Ostapoff, & Morest, 1991) . VNTB also receives inhibitory inputs, but their origin is not well described (Robertson, 1996) . Importantly, the VNTB is the main extrinsic source of inhibitory inputs to the MNTB . Representative images of presynaptic inputs to VNTB cells in Fmr1 2/2 and B6 animals are shown in Figure 3 . We found that in 
| Presynaptic structures of the MNTB (medial and lateral)
We next examined the inputs to the MNTB, which is another target that receives neural excitation from the contralateral AVCN, although via a different group of neurons (Smith, Joris, Carney, & Yin, 1991 Figures 6d and 8d) . The MNTB provides glycinergic inhibition to two independent sound localization processes, namely the analysis of interaural time differences (ITDs) at the MSO (Jeffress, 1948; Brand, Behrend, Marquardt, McAlpine, & Grothe, 2002 ) and the analysis of interaural intensity differences (IIDs) at the LSO (Caird & Klinke, 1983; Goldberg & Brown, 1969) In the medial, high frequency region of MNTB, we observed a decrease in number of GlyT2 presynaptic structures, but not VGLUT2 or GAD67 structures in the Fmr1 2/2 mouse compared to control (Figures 6a and 5 for representative images). At the same time, the mean structure size for all three antibodies were not significantly different in mice have fewer presynaptic GlyT2 structures compared to wildtype, but no change in VGLUT2 or GAD67 number (a). The mean structure size is unchanged in the medial MNTB of Fmr1 2/2 mice compared to wildtype for VGLUT2, GlyT2, or GAD67 structure size (b). The ratio (I sp ; see methods) of VGLUT2/GAD67 or VGLUT2/GlyT2 is unchanged in Fmr1 2/2 mice compared to wildtype (c). The MNTB receives excitation (pink) from the contralateral AVCN, inhibition from the VNTB (green (GlyT2)/blue (GAD67)) and projects inhibition to the ipsilateral LSO, each box plot represents data from an individual animal within the box plot of the group, orange/red indicates a B6 animal, purple/blue are Fmr1 2/2 animals (**p < .01) structures labeled for GAD67, but not GlyT2 or VGLUT2, are significantly decreased in the 
| Presynaptic structures of the LSO (medial and lateral)
Lastly, we examined the inputs to the LSO, which receives excitatory input from the ipsilateral AVCN and inhibitory input from the contralateral MNTB (as depicted in Figures 9d and 10d) . The LSO is also organized tonotopically and receives tonotopically organized glycinergic inhibitory input from the medial MNTB to the medial LSO for high frequency mice have fewer presynaptic GAD67 presynaptic structures compared to wildtype, but no change in VGLUT2 or GlyT2 (a). The mean structure size is unchanged for VGLUT2, GAD67, or GlyT2 structure size in Fmr1 2/2 mice compared to wildtype (b). The ratio (I sp ; see methods) of VGLUT2/GAD67 or VGLUT2/GlyT2 is unchanged in Fmr1 2/2 mice compared to wildtype (c). The MNTB receives excitation (pink) from the contralateral AVCN, inhibition from the VNTB (green (GlyT2)/blue (GAD67)) and projects inhibition to the ipsilateral LSO, box shows lateral MNTB (d). D is dorsal, L is lateral, each box plot represents data from an individual animal within the box plot of the group, orange/red indicates a B6 animal, purple/blue are Fmr1 2/2 animals, (*p < .05) sounds, and from the lateral MNTB to the lateral LSO for lower frequency sounds (Sommer, Lingenh€ ohl, & Friauf, 1993) . Note that the MSO is very small in the mouse due to their pronounced high-frequency hearing.,
In the medial LSO, there was no change in the number or size of presynaptic structures for any of the three antibodies between Fmr1 2/2 knockouts and controls (Figure 9a, b) . Consistent with no change in number of presynaptic structures, there was no difference in the ratio of VGLUT2/GAD67 or VGLUT2/GlyT2 in the medial LSO between Fmr1 2/2 mice compared to wildtype (Figure 9c ). The same was true for the lateral LSO where there was no change in the number or size presynaptic structures for GlyT2, VGLUT2, or GAD67 in Fmr1 2/2 mice compared to wildtype (Figure 10a , b, representative images in Figure   11 ). When we quantified the number of presynaptic structures as a ratio of VGLUT2/GAD67 or VGLUT2/GlyT2 (Figure 10c ), we saw no difference in I sp values between Fmr1 2/2 mice and controls.
| D I SCUSSION
We used triple immunofluorescence staining to examine changes in presynaptic excitatory and inhibitory synapses in the auditory brain- mice have no change in number of presynaptic structures for VGLUT2, GlyT2, and GAD67 compared to wildtype in the lateral LSO (a). There is no change in size of presynaptic structures in Fmr1 2/2 mice compared to wildtype (b). The ratio (I sp ; see methods) of VGLUT2/ GlyT2 or VGLUT2/GlyT2 is unaltered in Fmr1 2/2 mice compared to wildtype in the lateral LSO (c). The LSO receives excitation (pink) from the ipsilateral AVCN and inhibition from the ipsilateral MNTB (green (GlyT2)/blue (GAD67)), box shows lateral LSO (d). D is dorsal, L is lateral, each box plot represents data from an individual animal within the box plot of the group, orange/red indicates a B6 animal, purple/ blue are Fmr1 2/2 animals.
role for glycinergic inhibition in FXS, while previous studies have focused much more on GABAergic inhibition.
| AVCN
We see no change in overall number or size of presynaptic glutamatergic, glycinergic, or GABAergic structures in the AVCN of Fmr1 mice have no change in number of presynaptic structures for VGLUT2, GlyT2, and GAD67 compared to wildtype in the medial LSO (a). There is no change in size of presynaptic structures in Fmr1 2/2 mice compared to wildtype (b). The ratio (I sp ; see methods) of VGLUT2/ GlyT2 or VGLUT2/GlyT2 is unaltered in Fmr1 2/2 mice compared to wildtype in the medial LSO (c). The LSO receives excitation (pink) from the ipsilateral AVCN and inhibition from the ipsilateral MNTB (green (GlyT2)/blue (GAD67)), box shows medial LSO (d). D is dorsal, L is lateral, each box plot represents data from an individual animal within the box plot of the group, orange/red indicates a B6 animal, purple/ blue are Fmr1 2/2 animals
| VNTB
In the VNTB of Fmr1 2/2 mice we also observed no change in number or size of glutamatergic, glycinergic, or GABAergic puncta.
Anatomically, the VNTB receives excitatory input from the contralateral globular bushy cells of the AVCN (Bruce Warr, 1972; Helfert et al., 1989) . Physiologically, it has been shown that excitatory synapses projecting from the AVCN are thought to be the primary regulator of VNTB synaptic firing (Robertson 1996) . Where the inhibitory inputs (GABA and glycine) onto the VNTB originate from is not known. In guinea pigs, it has been shown that many of the cells in the VNTB have more GABAergic puncta than glycinergic suggesting that GABA plays a larger role in inhibition to this area (Helfert et al., 1989) . However, Albrecht et al. (2014) showed that, Awatramani, Turecek, & Trussell, 2004; Mayer et al., 2014) . The VNTB also consists of other cell types that are GABAergic or cholinergic in nature and it is not known where these cells project (Helfert et al., 1989; Yao & Godfrey, 1998) .
| MNTB
We saw tonotopic differences in the MNTB of Fmr1 2/2 mice, where in the medial, high frequency region of the MNTB, we see a decrease in number of glycinergic presynaptic structures, which could correlate with projections originating from the VNTB (though we did not see any changes in projections going to the VNTB). In contrast, in the lateral MNTB of Fmr1 2/2 mice there was no change in number of glycinergic presynaptic structures, but a significant decrease in GABAergic puncta.
The calyx of Held is a well-known and well-characterized strong glutamatergic synapse originating from the globular bushy cells in the AVCN and projecting to the contralateral MNTB (Guinan, Guinan, & Norris, 1972; Smith et al., 1991; Spangler et al., 1985) and we did not observe any alterations of this excitatory input in the knockout mice. Both
GABAergic and glycinergic inhibition onto the MNTB have been shown to originate from the ipsilateral VNTB and glycinergic axon collaterals from within the MNTB itself (Dondzillo et al., 2016) . Similar to the VNTB, most of the inhibition onto the MNTB is GABAergic during development; however, this inhibition changes into faster glycinergic inhibition in adulthood (Kotak, Korada, Schwartz, & Sanes, 1998) . Thus, one explanation for the differential alterations in high and low frequency contours of MNTB may be that the developmental shift from GABA to glycine is incomplete for afferents to the medial MNTB.
Traditionally, the MNTB has been thought to be merely a "relay station", converting incoming excitation into outgoing inhibition that is then used for the computation of level difference information between the two ears in the LSO. However, recently it has been shown that integration in the MNTB is likely more complex than previously thought (reviewed in Klug et al., 2012) . Additionally, the MNTB receives prominent inhibitory inputs, which are inconsistent with the concept of a relay station Awatramani et al., 2004; Dondzillo et al., 2016) . In FXS, where it is thought that there is hyperexcitability of sensory systems due to imbalances in the excitation and inhibition (Rubenstein & Merzenich, 2003) , impairments in MNTB processing may be particularly pronounced. However, recently it has been shown that despite changes in calyx morphology, there were no obvious changes in synaptic transmission in vivo in Fmr1 mice (Brown et al., 2010) , and an increase in Kv3.1 currents in medial (high frequency) MNTB (Strumbos et al., 2010) . These results would indicate that the MNTB of Fmr1 2/2 mice would likely have reduced temporal fidelity during high-frequency firing and inaccurate coding of modulation rate of stimulus features. Any disruptions in MNTB firing would likely alter ILD coding in the LSO since timing and strength of the inhibitory input from the contralateral ear through the MNTB is crucial for coding of this information. However, the MNTB also projects glycinergic inhibition to several other brain areas including the lateral lemniscus, MSO, and LNTB, among others, which were not measured in this study (Thompson & Schofield, 2000) .
| LSO
In Fmr1 2/2 mice, we saw no change in number or size of glycinergic, GABAergic, or glutamatergic presynaptic structures in either the medial or lateral LSO. The LSO receives excitatory input from ipsilateral spherical bushy cells in the AVCN (Cant & Casseday, 1986 ) and glycinergic inhibition from the ipsilateral MNTB (Tsuchitani, 1977) .
Electrophysiologically, alterations in LSO processing in Fmr1 2/2 mice or humans have not been studied. However, several studies have examined ABRs in Fmr1 2/2 mice and shown increased thresholds and decreased amplitudes of early ABR waveforms (which should correspond with brainstem level processing) (Rotschafer et al., 2015) . In patients with FXS, ABR measurements show longer peak latencies and inter-peak intervals of wave I-III, which again corresponds to abnormal processing in the brainstem circuit level (Ferri et al 1987) . Other studies however have shown dissimilar results or no differences in ABR measurements in FXS (Miezejeski et al., 1997; Roberts et al., 2005) . However, with ABR measurements, there are many variables that can account for differences in findings such as electrode placement, stimulation, etc. (reviewed in Ferber, Benichoux, & Tollin, 2016) . In autism, it has been shown that patients exhibit difficulties with sound localization on the vertical (monaural processing), but not horizontal plane (ILD processing) (Visser et al., 2013) . However, this study was conducted in adults, and generically with people who have autism-not FXS.
Whether there are in fact sound localization changes in patients with FXS has not been explored experimentally. One caveat to using the C57BL/6J strain (and many mouse strains), is that these mice exhibit age-related hearing loss at fairly young ages, therefore we cannot exclude the possibility that with our large age-range used in this study that one or more of the mice may have suffered from some agerelated hearing loss (Zheng, Johnson, & Erway, 1999) .
In summary, our study is the first to explore whether there are alterations in glycinergic inhibition in the auditory brainstem of Fmr1 2/2 mice. We also found that there are nucleus specific and frequency specific alterations of excitation versus inhibition in the auditory brainstem of the FXS knockout mouse. Additionally, our results suggest that due to the well-characterized functional roles of excitatory and inhibitory neurotransmitters in the auditory brainstem, the sound localization pathway is an ideal circuit by which to measure sensory alterations in FXS. A
